U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2109121091Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer ScreeningRecruitingNo Results AvailableAnxiety|No Evidence of Disease|Lung CarcinomaOther: educational intervention|Other: questionnaire administration|Other: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT02288416
2109221092Interval Versus Continuous Training in Healthy AdultsRecruitingNo Results AvailableHealthy VolunteersBehavioral: Aerobic interval training|Behavioral: Continuous traininghttps://ClinicalTrials.gov/show/NCT02288403
2109321093Oral Care as a Preventive Measure of VAP; Miswak Versus Chlorhexidine and Toothbrush.CompletedNo Results AvailableVentilator Associated PneumoniaProcedure: Oral care in mechanically ventilated patientshttps://ClinicalTrials.gov/show/NCT02288390
2109421094A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)RecruitingNo Results AvailableMetastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine TumoursDrug: lanreotidehttps://ClinicalTrials.gov/show/NCT02288377
2109521095Reducing Pain of Lidocaine InjectionRecruitingNo Results AvailablePain of Anesthesia at Breast BiopsyDrug: %1 Lidocaine|Drug: %1 Lidocaine plus sodium bicarbonatehttps://ClinicalTrials.gov/show/NCT02288364
2109621096Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric BypassWithdrawnNo Results AvailableType 2 Diabetes|ObesityOther: Mix Nutrient Meal|Other: labs|Other: Biopsy|Other: Second Mix Nutrient Meal|Other: Second biopsy|Device: PET/CThttps://ClinicalTrials.gov/show/NCT02288351
2109721097CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: 1 (Lipitor®)|Drug: 1 (Ezetrol®)|Drug: 1 (Lipitor®, Ezetrol®)|Drug: 2 (Ezetrol®)|Drug: 2(Lipitor®, Ezetrol®)|Drug: 2 (Lipitor®)|Drug: 3(Lipitor®, Ezetrol®)|Drug: 3 (Lipitor®)|Drug: 3 (Ezetrol®)|Drug: 4 (Lipitor®)|Drug: 4(Lipitor®, Ezetrol®)|Drug: 4 (Ezetrol®)|Drug: 5 (Ezetrol®)|Drug: 5 (Lipitor®)|Drug: 5 (Lipitor®, Ezetrol®)|Drug: 6(Lipitor®, Ezetrol®)|Drug: 6 (Ezetrol®)|Drug: 6 (Lipitor®)https://ClinicalTrials.gov/show/NCT02288338
2109821098A Multicenter, Relapse Prevention Study With Levomilnacipran ER in Patients With Major Depressive DisorderRecruitingNo Results AvailableDepressive Disorder, MajorDrug: Levomilnacipran ER|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02288325
2109921099Food Effect and Dosage Form Proportionality Study of Eslicarbazepine AcetateCompletedHas ResultsEpilepsyDrug: BIA 2-093https://ClinicalTrials.gov/show/NCT02288312
2110021100Long-Term Effect of LIAM on Respiratory Performance in NIV Patients Suffering From Neuromuscular DiseaseNot yet recruitingNo Results AvailableNeuromuscular DiseaseDevice: non invasive mechanical ventilationhttps://ClinicalTrials.gov/show/NCT02288299
2110121101Safety and Immunogenicity of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese HumansNot yet recruitingNo Results AvailableSafety, ImmunogenicityBiological: 2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 10-20 years old|Biological: 2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 21-50 years old|Biological: 2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 51-60 years old|Biological: 2.5IU/ml rabies vaccine(vero cell) in humans aged 10-20 years old|Biological: 2.5IU/ml rabies vaccine(vero cell) in humans aged 21-50 years old|Biological: 2.5IU/ml rabies vaccine(vero cell) in humans aged 51-60 years oldhttps://ClinicalTrials.gov/show/NCT02288286
2110221102Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: Bydureon|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02288273
2110321103RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet TherapyRecruitingNo Results AvailableAcute Coronary Syndromehttps://ClinicalTrials.gov/show/NCT02288260
2110421104A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide AloneRecruitingNo Results AvailableMetastatic Castration Resistant Prostate CancerDrug: Enzalutamide|Drug: Docetaxel|Drug: Prednisolone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02288247
2110521105Telavancin Observational Use Registry (TOUR)RecruitingNo Results AvailableHospital Acquired Pneumonia|Complicated Skin and Skin Structure Infections|Ventilator Associated Bacterial Pneumoniahttps://ClinicalTrials.gov/show/NCT02288234
2110621106Safe & Easy Environment at Home for Patients Presenting a Frail SyndromeNot yet recruitingNo Results AvailableCognitive DeteriorationOther: Patient's answer with non pharmacological therapeutic|Other: Patient's answer without non pharmacological therapeutichttps://ClinicalTrials.gov/show/NCT02288221
2110721107Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis BActive, not recruitingNo Results AvailableHepatitis BDrug: Antiviral Therapy (tenofovir or entecavir)|Drug: Birinapant|Drug: Placebo (for birinapant)https://ClinicalTrials.gov/show/NCT02288208
2110821108Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer PatientsRecruitingNo Results AvailableRectal NeoplasmsDrug: Oxaliplatin|Drug: capecitabine|Radiation: Radiationhttps://ClinicalTrials.gov/show/NCT02288195
2110921109A Randomized Controlled Clinical Trial to Investigate the Capability of Straumann VivOss Compared to Geistlich Bio-Oss in Sinus Floor AugmentationRecruitingNo Results AvailableHealthyDevice: Straumann VivOss|Device: Geistlich Bio-Osshttps://ClinicalTrials.gov/show/NCT02288182
2111021110Patient Outcomes of a Self-care Management Approach to Cancer Symptoms: A Clinical TrialRecruitingNo Results AvailableCancerBehavioral: COPE|Behavioral: Support/Attention Controlhttps://ClinicalTrials.gov/show/NCT02288169
2111121111Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic RhinitisNot yet recruitingNo Results AvailableNon-allergic RhinitisDrug: Capsaicinhttps://ClinicalTrials.gov/show/NCT02288156
2111221112COmbining Oral Letrozole and Clomiphene for Ovarian StimulationEnrolling by invitationNo Results AvailableInfertilityDrug: COOL-COShttps://ClinicalTrials.gov/show/NCT02288143
2111321113Ulipristal vs. GnRHa Prior to Laparoscopic MyomectomyRecruitingNo Results AvailableFibroidsDrug: GnRHa|Drug: Ulipristalhttps://ClinicalTrials.gov/show/NCT02288130
2111421114Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis StemRecruitingNo Results AvailableOsteoarthritis, Hip|Femur Head Necrosis|Femoral Neck Fractureshttps://ClinicalTrials.gov/show/NCT02288117
2111521115Needle-based Confocal Laser Endomicroscopy in CT-guided Procedures in Interventional Radiology With Applications in Liver and Kidneys: a Feasibility StudyRecruitingNo Results AvailableUndergo a Interventional Radiology Procedure on the Liver|Undergo a Interventional Radiology Procedure on the KidneyDevice: Dual Source CT - SOMATOM Definition from Siemens|Drug: Novartis sodium fluorescein|Device: Cellvizio with AQ-Flex confocal mini probe (Mauna Kea Technologies)https://ClinicalTrials.gov/show/NCT02288104
2111621116A Pilot Study of Inosine in ALSRecruitingNo Results AvailableAmyotrophic Lateral SclerosisDrug: Inosinehttps://ClinicalTrials.gov/show/NCT02288091
2111721117Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)RecruitingNo Results AvailableRectal CancerOther: General condition|Other: Blood pressure|Other: Patient Reported Outcome|Other: Clinical findings|Other: Hematology/blood chemistry|Other: Coagulation and fibrinolysis system|Other: Urinalysis|Other: Medication check|Other: Adverse event|Other: Thyroid function test|Other: Contrast-enhanced torso CT|Other: Brain MRI|Drug: Dexamethasone|Drug: Regorafenib|Drug: Placebo|Drug: Proton pump inhibitorhttps://ClinicalTrials.gov/show/NCT02288078
2111821118Predictive Factors and Outcome in Medical ThoracoscopyRecruitingNo Results AvailablePleuritisDrug: sterile talc pleurodesishttps://ClinicalTrials.gov/show/NCT02288065
2111921119Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's DiseaseRecruitingNo Results AvailableParkinson DiseaseBehavioral: Writing program|Behavioral: Stretch & Relaxation programhttps://ClinicalTrials.gov/show/NCT02288052
2112021120Quality of Life in Pulmonary Rehabilitation: A Social Identity Based InterventionRecruitingNo Results AvailableChronic Obstructive Pulmonary DiseaseOther: Social Identity goal-based Interventionhttps://ClinicalTrials.gov/show/NCT02288039

* Görseller ve İçerik tekif hakkına sahip olabilir